These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Bullous pemphigoid and related subepidermal autoimmune blistering diseases. Olasz EB; Yancey KB Curr Dir Autoimmun; 2008; 10():141-66. PubMed ID: 18460884 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of photodynamic therapy with topical 5-aminolevulinic acid using intense pulsed light for Bowen's disease. Hasegawa T; Suga Y; Mizuno Y; Haruna K; Ogawa H; Ikeda S J Dermatol; 2010 Jul; 37(7):623-8. PubMed ID: 20629828 [TBL] [Abstract][Full Text] [Related]
5. Investigation of the use of the pulsed dye laser in the treatment of Bowen's disease using 5-aminolaevulinic acid phototherapy. Britton JE; Goulden V; Stables G; Stringer M; Sheehan-Dare R Br J Dermatol; 2005 Oct; 153(4):780-4. PubMed ID: 16181460 [TBL] [Abstract][Full Text] [Related]
6. A child with antibodies targeting both linear IgA bullous dermatosis and bullous pemphigoid antigens. Darling TN; Cardenas AA; Beard JS; Sau P; Yee CL; Zone JJ; Yancey KB Arch Dermatol; 1995 Dec; 131(12):1438-42. PubMed ID: 7492135 [TBL] [Abstract][Full Text] [Related]
7. Photodynamic therapy for large or multiple patches of Bowen disease and basal cell carcinoma. Morton CA; Whitehurst C; McColl JH; Moore JV; MacKie RM Arch Dermatol; 2001 Mar; 137(3):319-24. PubMed ID: 11255332 [TBL] [Abstract][Full Text] [Related]
20. An open pilot study of ambulatory photodynamic therapy using a wearable low-irradiance organic light-emitting diode light source in the treatment of nonmelanoma skin cancer. Attili SK; Lesar A; McNeill A; Camacho-Lopez M; Moseley H; Ibbotson S; Samuel ID; Ferguson J Br J Dermatol; 2009 Jul; 161(1):170-3. PubMed ID: 19302071 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]